eli lilly retatrutide press release 2024 2025 says next-generation weight loss drug clears crucial obesity trial Lilly orforglipron oral GLP-1 phase

Synaptic co-release of thiamine and ACh, with thiamine facilitating the neurotransmission through its non-coenzyme action, is known from the early works of Minz and von Muralt on neuromuscular junctions (143, 165167)

While its preclinical promise is undeniable, its path to becoming a widely accepted and approved therapeutic agent requires a concerted effort to generate robust human clinical data, address regulatory concerns, and precisely define its optimal applications

Meat and Poultry: Beef, chicken, and turkey contain reliable amounts

Chronic gut inflammation and dysbiosis disrupt serotonin production (90% of serotonin is made in the gut), and disrupted serotonin undermines sleep quality